Minn. lawmaker tackles concerns about proposed 510(k) changes

08/22/2010 | Hill, The

Sen. Al Franken, D-Minn., on Friday held a conference with medical device companies in Minnesota to discuss their views on the changes proposed by the FDA to the 510(k) process for clearing medical products. Franken is seeking a meeting with FDA Commissioner Margaret Hamburg in September to relay the industry's concerns about the changes in an effort to "continue to foster medical innovation and protect patient safety."

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC